Please enable JavaScript.
Coggle requires JavaScript to display documents.
ADVANCE (PATIENTS (T2D, 33-55YRS, FOLLOWED UP FOR 4.3 YEARS, MORE THAN 11…
ADVANCE
PATIENTS
T2D
33-55YRS
FOLLOWED UP FOR 4.3 YEARS
MORE THAN 11 000
GLUCOSE LOWERING THERAPIES
INTENSIVE ARM
INSULIN
ANY OAD (EXCEPT SU)
LIFE STYLE CHANGES
DMR 60MG
STANDARD ARM
INSULIN
STANDARD CARE
ANY OAD
HBA1C TARGET
AT BEGINNING OF TRAIL HBA1C TARGET WAS < 6.5%
AT THE END OF THE STUDY
81 % OF PATIENTS HAD AN HBA1C TARGEWT OF 7%.
70% WERE ON OPTIMAL DOSE